EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudie

Natural history of ENPP1 deficiency: Nationwide Turkish Cohort Study of autosomal‐recessive hypophosphataemic rickets type 2

Fatma Dursun, İhsan Turan, Eda Çelebi Bitkin, Elvan Bayramoğlu, Atilla Çayır, Şenay Savaş Erdeve, Esra Deniz Papatya Çakır, Emine Çamtosun, Semine Ozdemir Dilek, Heves Kırmızıbekmez, Metin Eser, Ayberk Türkyılmaz und 1 weitere

Clinical Endocrinology · 2024-11 · 101 (5) · 475-484

DOI: 10.1111/cen.15028 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Endocrinology, online erschienen am 07.02.2024. Verfasst von Fatma Dursun und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Endocrinology, SBU Umraniye Training and Research Hospital, University of Health Science, Istanbul, Türkiye. Hauptthemen laut MEDLINE: Phosphoric Diester Hydrolases, Pyrophosphatases, Familial Hypophosphatemic Rickets. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Autosomal‐recessive hypophosphataemic rickets type 2 (ARHR2) is a rare disease that is reported in survivors of generalized arterial calcification of infancy (GACI). Design, Patients and Measurement The objective of this study was to characterize a multicenter paediatric cohort with ARHR2 due to ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (ENPP1) deficiency and with a diagnosis of GACI or GACI‐related findings. The clinical, biochemical and genetic characteristics of the patients were retrospectively retrieved.

Results

We identified 18 patients from 13 families diagnosed with ARHR2. Fifteen of the patients had an ENPP1 variation confirmed with genetic analyses, and three were siblings of one of these patients, who had clinically diagnosed hypophosphataemic rickets (HRs) with the same presentation. From nine centres, 18 patients, of whom 12 (66.7%) were females, were included in the study. The mean age at diagnosis was 4.2 ± 2.2 (1.6–9) years. The most frequently reported clinical findings on admission were limb deformities (66.6%) and short stature (44.4%). At diagnosis, the mean height SD was −2.2 ± 1.3. Five of the patients were diagnosed with GACI in the neonatal period and treated with bisphosphonates. Other patients were initially diagnosed with ARHR2, but after the detection of a biallelic variant in the ENPP1 gene, it was understood that they previously had clinical findings associated with GACI. Three patients had hearing loss, and two had cervical fusion. After the treatment of HRs, one patient developed calcification, and one developed intimal proliferation.

Conclusion

ARHR2 represents one manifestation of ENPP1 deficiency that usually manifests later in life than GACI. The history of calcifications or comorbidities that might be associated with GACI will facilitate the diagnosis in patients with ARHR2, and patients receiving calcitriol and phosphate medication should be carefully monitored for signs of calcification or intimal proliferation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Phosphoric Diester HydrolasesPyrophosphatasesFamilial Hypophosphatemic RicketsHumansFemaleMaleChildInfantChild, PreschoolRetrospective StudiesTurkeyCohort StudiesVascular Calcification

Stichwörter der Autor:innen

ENPP1 deficiencyautosomal‐recessive hypophosphataemic rickets type 2generalized arterial calcification of infancy

Substanzen

Phosphoric Diester HydrolasesPyrophosphatasesectonucleotide pyrophosphatase phosphodiesterase 1

Autor:innen und Institutionen

  • Department of Pediatric Endocrinology, SBU Umraniye Training and Research Hospital, University of Health Science, Istanbul, Türkiye.
  • Department of Pediatric Endocrinology, Faculty of Medicine, Cukurova University, Adana, Türkiye.
  • Department of Pediatric Endocrinology, Bakırkoy Dr Sadi Konuk Training and Research Hospital, Istanbul, Türkiye.
  • Department of Pediatric Endocrinology, Cerrahpaşa Faculty of Medicine, Istanbul University, İstanbul, Türkiye.
  • Department of Pediatric Endocrinology and Diabetes, Erzurum Education and Research Hospital, University of Health Science, Erzurum, Türkiye.
  • Department of Pediatric Endocrinology, Ankara Etlik City Hospital, University of Health Science, Ankara, Türkiye.

Zitieren

APA

Dursun, F., Turan, İ., Bitkin, E. Ç., Bayramoğlu, E., Çayır, A., Erdeve, Ş. S., Çakır, E. D. P., Çamtosun, E., Dilek, S. O., Kırmızıbekmez, H., Eser, M., Türkyılmaz, A., & Karagüzel, G. (2024). Natural history of ENPP1 deficiency: Nationwide Turkish Cohort Study of autosomal‐recessive hypophosphataemic rickets type 2. Clinical Endocrinology, 101(5), 475-484. https://doi.org/10.1111/cen.15028

Vancouver

Dursun F, Turan İ, Bitkin EÇ, Bayramoğlu E, Çayır A, Erdeve ŞS, et al. Natural history of ENPP1 deficiency: Nationwide Turkish Cohort Study of autosomal‐recessive hypophosphataemic rickets type 2. Clinical Endocrinology. 2024;101(5):475-484. doi:10.1111/cen.15028

BibTeX
@article{Dursun2024,
  author = {Dursun, Fatma and Turan, İhsan and Bitkin, Eda Çelebi and Bayramoğlu, Elvan and Çayır, Atilla and Erdeve, Şenay Savaş and Çakır, Esra Deniz Papatya and Çamtosun, Emine and Dilek, Semine Ozdemir and Kırmızıbekmez, Heves and Eser, Metin and Türkyılmaz, Ayberk and Karagüzel, Gülay},
  title = {Natural history of ENPP1 deficiency: Nationwide Turkish Cohort Study of autosomal‐recessive hypophosphataemic rickets type 2},
  journal = {Clinical Endocrinology},
  year = {2024},
  volume = {101},
  number = {5},
  pages = {475--484},
  doi = {10.1111/cen.15028}
}
Kostenlos starten →